MCL1 and Miyoshi myopathy: Collectively, these findings argue that inactivation of STAT3 and down-regulation of downstream targets e.g., c-MYC, BCL-XL, MCL-1 contribute functionally to cell death induction by ATR inhibitors in MM cells.